Beijing Luzhu Biotechnology (1868402D CH)

Analysis

Health Care • China

Beijing Luzhu Biotechnology Co., Ltd. operates pharmaceutical development businesses. The Company develops human monoclonal antibodies, bispecific antibody drugs, recombinant viral vaccines, and other products. Beijing Luzhu Biotechnology conducts businesses in China.

Refresh

Request Primer

No publications yet

No AI primers are available right now. Create one using Smartkarma AI.

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00